Pfizer SARS-CoV-2 protease inhibitor PF-07321332 and SARS-CoV-2 protease, molecular models. The image shows the protease (top) and the inhibitor (bottom). As of 2021, the clinical candidate PF-07321332 is a potent protease inhibitor with potent anti-viral activity against SARS-CoV-2. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Laguna Design |
Bildgröße: | 5000 px × 3750 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |